Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
09/1999
09/23/1999WO1999047923A2 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
09/23/1999WO1999047703A1 Method for producing agents for treating tumour diseases and for immunosuppression
09/23/1999WO1999047685A1 Improvements in or relating to fatty acid metabolism
09/23/1999WO1999047678A2 Interferon alpha plasmids and delivery systems, and methods of making and using the same
09/23/1999WO1999047677A2 Polypeptides homologous to vegf and bmp1
09/23/1999WO1999047674A2 Compounds and methods for therapy and diagnosis of lung cancer
09/23/1999WO1999047673A2 Isolated mammalian membrane protein genes and related reagents
09/23/1999WO1999047672A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
09/23/1999WO1999047671A2 Dna sequences encoding semaphorin-h and diagnosis of metastatic cancer
09/23/1999WO1999047670A1 Mammalian sodium channel proteins
09/23/1999WO1999047669A2 Human nucleic acid sequences from tissue of breast tumors
09/23/1999WO1999047662A1 Staphylococcus aureus genes and polypeptides
09/23/1999WO1999047658A1 The cytokine family member ef-7
09/23/1999WO1999047655A2 Human nucleic acid fragments with heightened expression in normal breast tissue
09/23/1999WO1999047652A2 Novel rnase-like protein and its use
09/23/1999WO1999047651A1 HALOPEROXIDASES WITH ALTERED pH PROFILES
09/23/1999WO1999047649A2 Polymerase chimeras
09/23/1999WO1999047641A1 Compositions and methods for gene-based vaccines to provoke t cell responses
09/23/1999WO1999047640A1 Method for identifying proteases, protease target sites and regulators of protease activity in cells
09/23/1999WO1999047639A2 Staphylococcus aureus genes and polypeptides
09/23/1999WO1999047564A1 Fas-associated polypeptides
09/23/1999WO1999047553A2 Bacterial yeal family members as targets for antimicrobial drug design
09/23/1999WO1999047544A1 nrdF
09/23/1999WO1999047540A1 95 human secreted proteins
09/23/1999WO1999047539A1 Thermostable dna polymerase from thermoanaerobacter thermohydrosulfuricus
09/23/1999WO1999047538A1 Cytokine receptor common gamma chain like
09/23/1999WO1999047537A1 Staphylococcus aureus spo0j2: polynucleotide and protein
09/23/1999WO1999047535A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS
09/23/1999WO1999047147A1 nrdG
09/23/1999WO1999041379A3 Members of the d52 gene family
09/23/1999WO1999041374A3 Human short-chain tnf-receptor family protein
09/23/1999WO1999038986A3 Riboflavin biosynthesis genes from plants and uses thereof
09/23/1999WO1999037774A8 Differentiation-associated sequences and methods of use therefor
09/23/1999WO1998015284A3 Mycosis vaccines
09/23/1999DE19813839A1 Human nucleic acid sequences and protein products from tumor breast tissue, useful for breast cancer therapy
09/23/1999DE19813835A1 Human nucleic acid sequences and protein products from normal breast tissue, useful for breast cancer therapy
09/23/1999CA2625284A1 Modulators of the function of receptors of the tnf/ngf receptor family
09/23/1999CA2324248A1 Thermostable dna polymerase from thermoanaerobacter thermohydrosulfuricus
09/23/1999CA2323830A1 Methods and compositions for diagnosing and treating chromosome-18p related disorders
09/23/1999CA2323762A1 Improvements in or relating to fatty acid metabolism
09/23/1999CA2323761A1 95 human secreted proteins
09/23/1999CA2323725A1 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
09/23/1999CA2323724A1 Staphylococcus aureus genes and polypeptides
09/23/1999CA2323637A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
09/23/1999CA2323604A1 Interferon alpha plasmids and delivery systems, and methods of making and using the same
09/23/1999CA2323093A1 Compounds and methods for therapy and diagnosis of lung cancer
09/23/1999CA2323083A1 Isolated mammalian membrane protein genes and related reagents
09/23/1999CA2322781A1 Haloperoxidases with altered ph profiles
09/23/1999CA2322659A1 Compositions and methods for gene-based vaccines to provoke t cell responses
09/23/1999CA2321091A1 An equine neospora isolate and its uses
09/23/1999CA2249662A1 Novel compounds
09/22/1999EP0943687A2 Method of producing L-serine by fermentation
09/22/1999EP0943686A2 Protein participating in activation of nitrile hydratase,gene,plasmid and a process for producing an amide
09/22/1999EP0943685A2 G-protein coupled receptor from human brain
09/22/1999EP0943684A2 Frizzled-like polypeptides and polynucleotides
09/22/1999EP0943679A1 Novel RNase-like protein and its use
09/22/1999EP0943678A2 Lipase variants
09/22/1999EP0943009A2 Species-specific, genus-specific and universal dna probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
09/22/1999EP0942989A1 Method for the production of 1,3-propanediol by recombinant organisms
09/22/1999EP0942985A1 Broad-spectrum delta-endotoxins
09/22/1999EP0942984A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
09/22/1999EP0942983A2 $i(STREPTOCOCCUS PNEUMONIAE) ANTIGENS AND VACCINES
09/22/1999EP0942982A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof
09/22/1999EP0942981A1 Fibroblast growth factor-13
09/22/1999EP0942980A1 Tumor-associated kazal inhibitor with pec-60 homology
09/22/1999EP0942977A2 Nucleic acid encoding schwannomin-binding-proteins and products related thereto
09/22/1999EP0942975A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses
09/22/1999EP0942973A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use
09/22/1999EP0942970A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof
09/22/1999EP0942965A2 Novel genes coding for amino acid deacetylases with specificity for n-acetyl-l-phosphinothricin, their isolation and their use
09/22/1999EP0942964A2 Thermostable polymerases having altered fidelity
09/22/1999EP0942935A1 A process for purifying apolipoproteins and a composition for use in the process
09/22/1999EP0942933A1 Human kdel receptor
09/22/1999EP0942929A1 Dna encoding lepidopteran-active delta-endotoxins and its use
09/22/1999EP0540525B1 Method of preparation of vaccines, and the use of the vaccines thus prepared
09/22/1999CN1229439A Fusion polypeptides comprising an IgE-binding domain and a HSA component, and their diagnostic and therapeutic uses
09/22/1999CN1229438A Erythromycins and process for their preparation
09/22/1999CN1229358A Method for generating bi-RNA-virus from synthetic RNA transcripts
09/22/1999CN1229134A Genetically engineered L-sorbose reductase-deficient mutants
09/22/1999CN1229133A Insulin kind growth faltor-1 engineering bacteria structure and method for preparation of eka-insulin growth factor-1
09/22/1999CN1045208C Isoamyl tadine compound, its preparation method and microbe for producing the compound
09/21/1999US5955602 Natural soluble polysaccharide of lactose possibly substituted with galactose, glucose, n-acetylgalactosamine, n-acetylneuramic acid, fucose, or sulfation; for use in cosmetics and food
09/21/1999US5955592 Nucleotide and amino acid sequences; for diagnosis of susceptiblity to cancer or diabetes
09/21/1999US5955583 Antibodies which bind to cyclic guanosine 3', 5' monophosphate enzyme involved in signal transduction
09/21/1999US5955580 Vaccines for nontypable haemophilus influenzae
09/21/1999US5955448 Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
09/21/1999US5955429 Human apoptosis-associated protein
09/21/1999US5955428 DNA encoding human metallothionein
09/21/1999US5955420 Exposing cell comprising rse receptor to exogenous growth arrest-specific gene 6 (gas6) polypeptide to activate receptor; treating neurologic disorders
09/21/1999US5955368 Expression system for clostridium species
09/21/1999US5955367 Production of bacillus thuringiensis integrants
09/21/1999US5955366 Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins
09/21/1999US5955359 Method of growing granulocytic ehrlichiae of the Ehrlichia phagocytophila genogroup in promyelocytic leukemia cell culture, and preparing antigens and vaccines of said granulocytic ehrlichiae
09/21/1999US5955356 Nucleic acids, vectors, and host cells including mycobacterium derived sequences
09/21/1999US5955349 Compositions and methods for producing heterologous polypeptides in Pichia methanolica
09/21/1999US5955347 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
09/21/1999US5955346 Variants of human prolactin and human placeatal lactogen
09/21/1999US5955338 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase
09/21/1999US5955337 Lyase enzyme which can be used to screen fungicidal compounds
09/21/1999US5955332 Polynucleotide sequence that codes for a protein that prevents viral infection of lactic acid bacteria; for production of dairy products and other foods